Skip to main content
Notice2026-11502

National Cancer Institute; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 9, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 110 (Tuesday, June 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 110 (Tuesday, June 9, 2026)]
[Notices]
[Pages 34828-34829]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-11502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board.
    The meeting will be held as a virtual meeting and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below in 
advance of the meeting. The meeting can be accessed from the NIH 
Videocast at the following link: <a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory.
    Date: September 2, 2026.
    Open: 9:00 a.m. to 12:20 p.m.
    Agenda: National Cancer Advisory Board Subcommittee Meetings.
    Open: 12:30 p.m. to 4:00 p.m.
    Agenda: Director's and Program reports and presentations; 
business of the Board.
    Closed: 4:10 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications and 
discussions of confidential personnel issues.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 and 408, Rockville, MD 20850 (Virtual 
Meeting).
    Contact Person: Shamala K. Srinivas, Ph.D., Acting Director, 
Division of Extramural Activities, National Cancer Institute--Shady 
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th 
Floor, Room 7W530, Bethesda, MD 20892, 240-276-6340, 
<a href="/cdn-cgi/l/email-protection#0c7f646d616d606d4c616d656022626564226b637a"><span class="__cf_email__" data-cfemail="b4c7dcd5d9d5d8d5f4d9d5ddd89adadddc9ad3dbc2">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page:
    NCAB: <a href="https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm">https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm</a>, where an

[[Page 34829]]

agenda, instructions for accessing the virtual NCAB meetings, and 
any additional information for the meetings will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 4, 2026.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2026-11502 Filed 6-8-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on June 9, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.